Noninvasive PK11195‐PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson's Disease

Neuroinflammation has been implicated in the pathophysiology of Parkinson's disease (PD), which might be influenced by successful neuroprotective drugs. The uptake of [11C](R)‐PK11195 (PK) is often considered to be a proxy for neuroinflammation, and can be quantified using the Logan graphical method with an image‐derived blood input function, or the Logan reference tissue model using automated reference region extraction. The purposes of this study were (1) to assess whether these noninvasive image analysis methods can discriminate between patients with PD and healthy volunteers (HVs), and (2) to establish the effect size that would be required to distinguish true drug‐induced changes from system variance in longitudinal trials.

[1]  J. Fleiss,et al.  Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.

[2]  O. Inoue,et al.  Synthesis and evaluation of11C-PK 11195 forin vivo study of peripheral-type benzodiazepine receptors using position emission tomography , 1989 .

[3]  O. Inoue,et al.  Synthesis and evaluation of 11C-PK 11195 for in vivo study of peripheral-type benzodiazepine receptors using positron emission tomography. , 1989, Annals of nuclear medicine.

[4]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[5]  S. Hume,et al.  Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. , 1994, Nuclear medicine and biology.

[6]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[7]  N. Volkow,et al.  Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  J. Logan Graphical analysis of PET data applied to reversible and irreversible tracers. , 1999, Nuclear medicine and biology.

[9]  Roger N Gunn,et al.  Positron Emission Tomography Compartmental Models: A Basis Pursuit Strategy for Kinetic Modeling , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  Ronald Boellaard,et al.  Development of a Tracer Kinetic Plasma Input Model for (R)-[11C]PK11195 Brain Studies , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  Alexander Hammers,et al.  In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease , 2006, Neurobiology of Disease.

[12]  F. Turkheimer,et al.  Reference and target region modeling of [11C]-(R)-PK11195 brain studies. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  Tuula Tolvanen,et al.  Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  Sarah H Lisanby,et al.  Safety of Radial Arterial Catheterization in PET Research Subjects , 2009, Journal of Nuclear Medicine.

[15]  Tim Mulnix,et al.  A multimodal approach to image-derived input functions for brain PET , 2009, 2009 IEEE Nuclear Science Symposium Conference Record (NSS/MIC).

[16]  M. Goldberg,et al.  Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention , 2010, Neurobiology of Disease.

[17]  Max A. Viergever,et al.  elastix: A Toolbox for Intensity-Based Medical Image Registration , 2010, IEEE Transactions on Medical Imaging.

[18]  Kewei Chen,et al.  Image-Derived Input Function for Brain PET Studies: Many Challenges and Few Opportunities , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[19]  Ronald Boellaard,et al.  Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[11C]PK11195 brain PET studies , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  Roger N Gunn,et al.  An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  Christer Halldin,et al.  Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects , 2012, EJNMMI Research.

[22]  Masahiro Fujita,et al.  Population-based input function and image-derived input function for [11C](R)-rolipram PET imaging: Methodology, validation and application to the study of major depressive disorder , 2012, NeuroImage.

[23]  B. Lopresti,et al.  Molecular imaging of microglia/macrophages in the brain , 2013, Glia.

[24]  Torbjörn Falkmer,et al.  The Case for Using the Repeatability Coefficient When Calculating Test–Retest Reliability , 2013, PloS one.

[25]  Alan A. Wilson,et al.  Imaging Striatal Microglial Activation in Patients with Parkinson’s Disease , 2015, PloS one.

[26]  Alessandra Bertoldo,et al.  The methodology of TSPO imaging with positron emission tomography , 2015, Biochemical Society transactions.

[27]  Jia-wei Zhou,et al.  Neuroinflammation in Parkinson’s disease and its potential as therapeutic target , 2015, Translational Neurodegeneration.

[28]  Drew A. Torigian,et al.  Repeatability of 18F-FDG PET/CT in Advanced Non–Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials , 2015, The Journal of Nuclear Medicine.

[29]  T. O'Brien,et al.  Imaging Microglial Activation with TSPO PET: Lighting Up Neurologic Diseases? , 2016, The Journal of Nuclear Medicine.

[30]  Sumit Sarkar,et al.  Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives , 2016, International journal of molecular sciences.

[31]  W. Le,et al.  Protective Microglia and Their Regulation in Parkinson’s Disease , 2016, Front. Mol. Neurosci..

[32]  Nicholas Petrick,et al.  Statistical Issues in Testing Conformance with the Quantitative Imaging Biomarker Alliance (QIBA) Profile Claims. , 2016, Academic radiology.

[33]  A. Gerhard TSPO imaging in parkinsonian disorders , 2016, Clinical and Translational Imaging.

[34]  R. Ransohoff How neuroinflammation contributes to neurodegeneration , 2016, Science.

[35]  Hans J. Johnson,et al.  Advanced Normalization Tools (ANTs) , 2020 .